Some clinical characteristics are fundamental for therapy decision, such as lymph node metastasis, hormone receptors status, human epidermal growth factor receptor 2 (HER2) expression and types of metastatic site [23]. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.